ScholarIQanswers from OpenAlex & ORCID
Seymour Katz
ResearcherPublications, citations & collaboration network
Seymour Katz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Seymour Katz have?
ScholarIQindexed works
Seymour Katz has 391 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Seymour Katz have?
ScholarIQcitation count
Seymour Katz has 16,898 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Seymour Katz?
ScholarIQh-index
Seymour Katz has an h-index of 60 in OpenAlex.
What is the i10-index of Seymour Katz?
ScholarIQi10-index
Seymour Katz has an i10-index of 147 in OpenAlex.
What is the ORCID of Seymour Katz?
ScholarIQorcid
The ORCID for Seymour Katz is on the source record.
What is the OpenAlex record for Seymour Katz?
ScholarIQopenalex
The OpenAlex for Seymour Katz is on the source record.
What are the most-cited papers on Seymour Katz?
ScholarIQmost cited works
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Brian G. Feagan, William J. Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R. Friedman, Marion Blank, Jewel Johanns, Long-Long Gao, Miao Ye, Omoniyi J. Adedokun, Bruce E. Sands, Stephen B. Hanauer, Séverine Vermeire, Stephan R. Targan, Subrata Ghosh, Willem J. de Villiers, Jean–Frédéric Colombel, Zsolt Tulassay, Ursula Seidler, Bruce Salzberg, Pierre Desreumaux, Scott D. Lee, Edward V. Loftus, Levinus A. Dieleman, Seymour Katz, Paul Rutgeerts
Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein.
Jean‐Michel Foidart, EW Bere, Mina Yaar, S. I. Rennard, Marisa Gullino, George R. Martin, Seymour Katz
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
William J. Sandborn, William J. Sandborn, Subrata Ghosh, Julian Panes, Ivana Vranić, Wenjin Wang, Wojciech Niezychowski, Séverine Vermeire, Olivier Dewit, Harald Peeters, Jiřı́ Stehlı́k, Tomáš Vaňásek, David Laharie, Jean Frédéric Colombel, M A Bigard, Márta Varga, Margit Zeher, János Novák, Béla Hunyady, Á Salamon, I Rácz, Paolo Gionchetti, Anna Kohn, Cosimo Prantera, Pieter Stokkers, Maria Słomka, Leszek Paradowski, Tomasz Arłukowicz, L Kuzela, Boris Baricky, Tibor Hlavatý, María Isabel Vera-Muñoz, Julian Panes, Jordi Guardiola, C Probert, JL Shaffer, Mark Fleisher, Ronald Edward Pruitt, William J. Sandborn, William J. Sandborn, John S. Goff, John T. Weber, R. Bell, Andrew Zwick, Alexandra Gutierrez, Robert H. Levine, Stephen Brett Hanauer, Lori Ann Lavelle, Ravindranath Kottoor, Gerald Wayne Dryden, Robert Hardi, David Vaughn Glorioso, Prabhakar Swaroop, Scott D. Lee, Teressa Joan Patrick, Sheldon Scheinert, Charles A. Sninsky, Seymour Katz, Mark D. Noar, Marco Gaspari, Glenn L. Gordon, Thomas A. Dalton, Douglas Edward Homoky, William Ransom Kilgore, Joel A. Levien, Herbert R. Schneider, S. Moola, Frederik Cornelius Kruger, John Wright, Nazimuddin Aboo
Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease
Alan L. Buchman, Seymour Katz, John C. Fang, Çharles N. Bernstein, Souheil G. Abou‐Assi